熱門資訊> 正文
ASTS、ALLO和CRCM均为上市前涨幅股
2024-05-21 20:26
- Gainers: Biodexa Pharmaceuticals (BDRX) +61%.
- Edible Garden (EDBL) +48%.
- Meta Materials (MMAT) +34% Announces Update on Naked Short Selling Investigation.
- Mmtec (MTC) +24%.
- Larimar Therapeutics (LRMR) +20% stock rallies 24% on FDA removal of partial clinical hold
- LM Funding America (LMFA) +15%.
- Cheetah Mobile (CMCM) +14%.
- Allogene Therapeutics (ALLO) +12%.
- BriaCell Therapeutics (BCTX) +13%.
- SILO Pharma (SILO) +9%.
- Durect (DRRX) +12% Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis.
- BYND Cannasoft Enterprises (BCAN) +7%.
- Mobile health Network Solutions (MNDR) +7%.
- AST SpaceMobile (ASTS) +7%.
- Earlyworks (ELWS) +7%.
- AGBA Group Holding (AGBA) +7%.
- MAIA Biotechnology (MAIA) +5%.
More on premarket gainers & stock
- LM Funding America, Inc. (LMFA) Q1 2024 Earnings Call Transcript
- LM Funding America, Inc. (LMFA) Q4 2023 Earnings Call Transcript
- BriaCell falls on $5M stock offering
- LM Funding America mines 24.7 bitcoins in April
- Seeking Alpha’s Quant Rating on Briacell Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
